Teixeira RJ, de Souza VG, Sorroche BP, Paes VG, et al. Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy. Melanoma Res 2024 Feb 16. doi: 10.1097/CMR.0000000000000958.
PMID: 38364053